Schedule of Convertible Note Payable |
Convertible
note payable, related party consists of the following at September 30, 2023 and December 31, 2022, respectively:
Schedule
of Convertible Note Payable Related Party
|
|
September 30, |
|
|
December 31, |
|
|
|
2023 |
|
|
2022 |
|
On September 27, 2022 |
|
|
750,000 |
|
|
|
750,000 |
|
On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $750,000 (the “Convertible McCabe Note”) to Dr. John McCabe, an affiliate investor. The unsecured note matures on September 16, 2024 (the “Maturity Date”), bears interest at a rate of 8% per annum, and the principal and interest is convertible into shares of the Company’s convertible Series B common stock at a conversion price of $15 per share. |
|
$ |
750,000 |
|
|
$ |
750,000 |
|
|
|
|
|
|
|
|
|
|
Total convertible note payable, related party |
|
|
750,000 |
|
|
|
750,000 |
|
Less: current maturities |
|
|
- |
|
|
|
- |
|
Convertible note payable, related party, long-term portion |
|
$ |
750,000 |
|
|
$ |
750,000 |
|
|
Convertible
note payable consists of the following at December 31, 2022 and 2021, respectively:
Schedule
of Convertible Note Payable
|
|
December
31, |
|
|
December
31, |
|
|
|
2022 |
|
|
2021 |
|
On September 27, 2022, |
|
$ |
750,000 |
|
|
$ |
- |
|
On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the
principal amount of $750,000
(the “Convertible McCabe Note”) to Dr. John McCabe. The unsecured note matures on 16, 2024 (the “Maturity
Date”), bears interest at a rate of 8%
per annum, and the principal and interest is convertible into shares of the Company’s convertible Series B common stock at
a conversion price of $15
per share. |
|
$ |
750,000 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
On
September 24, 2021, the Company completed the sale of a (i) Promissory Note in the principal
amount of $750,000
(the
“Second AJB Note”) to AJB Capital Investments LLC (“AJB Capital”),
(ii) a three-year
warrant to purchase 1,500,000
shares
of the Company’s common stock at an initial exercise price of $0.25
per
share, and (iii) a three-year
warrant to purchase 2,000,000
shares
of the Company’s common stock at an initial exercise price of $0.50
per
share, for an aggregate purchase price of $705,000,
pursuant to a Securities Purchase Agreement between the Company and AJB Capital (the “Purchase
Agreement”). The aggregate estimated value using the Black-Scholes Pricing Model, based
on a volatility rate of 197%
and a call option value of $0.1053
and
$0.1001,
respectively, was $358,017,
and is being amortized as a debt discount over the life of the loan. The Company received
net proceeds of $678,750
after
deductions of debt discounts, consisting of $45,000
pursuant
to an original issue discount, $15,000
of
legal fees and $11,250
of
brokerage fees.
The
Note matures on September
24, 2022 (the
“Maturity Date”), bears interest at a rate of 8%
per annum, and, following an event of default only, is convertible into shares of the Company’s
common stock at a conversion price equal to the lesser of 90% of the lowest trading price
during (i) the 20
trading
day period preceding the issuance date of the note, or (ii) the 20 trading day period preceding
date of conversion of the Note. The Note is also subject to covenants, events of defaults,
penalties, default interest and other terms and conditions customary in transactions of this
nature.
Pursuant
to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount
of $250,000
(the
“Commitment Fee”) in the form of 1,250,000
shares
of the Company’s common stock (the “Commitment Fee Shares”). During the
six month period following the six month anniversary of the closing date, AJB Capital shall
be entitled to be issued additional shares of common stock of the Company to the extent AJB
Capital’s sale of the Commitment Fee Shares has resulted in net proceeds in an amount
less than the Commitment Fee. The Commitment Fee Shares resulted in a debt discount of $150,062
that
is being amortized over the life of the loan.
The
obligations of the Company to AJB Capital under the Note and the Purchase Agreement are secured
by a lien on the Company’s assets pursuant to a Security Agreement between the Company
and AJB Capital. The note was repaid on September 27, 2022.
|
|
$ |
- |
|
|
$ |
750,000 |
|
|
|
|
|
|
|
|
|
|
Total convertible notes
payable |
|
|
750,000 |
|
|
|
750,000 |
|
Less:
unamortized debt discounts |
|
|
- |
|
|
|
412,673 |
|
Convertible
note payable, net of discounts |
|
$ |
750,000 |
|
|
$ |
337,327 |
|
|
Schedule of Convertible Debt Discounts |
|
The
Company recognized debt discounts for the years ended December 31, 2022 and 2021, as follows:
Schedule
of Convertible Debt Discounts
|
|
December
31, |
|
|
December
31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
Fair value
of 3,250,000
commitment shares of common stock
|
|
$ |
106,894 |
|
|
$ |
418,312 |
|
Fair value of warrants
to purchase 3,500,000
shares of common stock
|
|
|
255,026 |
|
|
|
358,017 |
|
Original issue discounts |
|
|
32,055 |
|
|
|
53,700 |
|
Legal
and brokerage fees |
|
|
18,698 |
|
|
|
39,300 |
|
Total
debt discounts |
|
|
412,673 |
|
|
|
869,329 |
|
Amortization
of debt discounts |
|
|
412,673 |
|
|
|
456,656 |
|
Unamortized
debt discounts |
|
$ |
- |
|
|
$ |
412,673 |
|
|